Form 4: Nu Skin EVP Sells 20,000 Shares Under 10b5-1 Plan

Nu Skin Enterprises' EVP and General Counsel, Chayce David Clark, sold 20,000 shares of Class A Common Stock for approximately $239,400 through a pre-arranged 10b5-1 plan.

Summary

• Chayce David Clark, Executive Vice President and General Counsel of Nu Skin Enterprises, Inc. (NUS), reported the sale of 20,000 shares of Class A Common Stock.
• The transaction occurred on September 3, 2025, at a weighted-average price of $11.97 per share.
• Shares were sold in multiple transactions with prices ranging from $11.96 to $12.01, inclusive.
• This sale was conducted pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction.
• Following the sale, Mr. Clark directly beneficially owns 233,140 shares of Nu Skin Class A Common Stock.

Sentiment

Score: 4

Explanation: The sale by a key executive, even if pre-planned, can be perceived negatively by the market as it reduces insider ownership. However, the 10b5-1 plan mitigates the negative signal somewhat, suggesting a planned financial move rather than a reaction to adverse non-public information.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale and not necessarily a reaction to new, non-public information, which can mitigate negative market perception.

Negatives

• An executive, Chayce David Clark, sold 20,000 shares of company stock, which can be interpreted as a reduction in insider confidence or a move to diversify personal holdings.
• The sale value of approximately $239,400 represents a significant divestment by a key executive.

Risks

• Potential for negative market perception due to an executive selling a substantial number of shares, even if pre-planned.
• The sale could be interpreted by some investors as a signal of limited upside potential or a lack of strong conviction in the company's near-term performance.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May interpret the sale as a slight negative signal regarding executive confidence, potentially leading to short-term price fluctuations, although the 10b5-1 plan lessens this impact.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the reported range upon request to the issuer, security holders, or the SEC staff.

Key Dates

Recommendation

While an executive sale can be a negative signal, the transaction was conducted under a Rule 10b5-1 plan, suggesting a pre-scheduled personal financial decision rather than a reaction to new, adverse company-specific information. Without further context on the company's fundamentals or broader market conditions, a 'hold' recommendation is appropriate, advising investors to monitor future developments and company performance rather than reacting solely to this insider transaction.

Keywords

Nu Skin Enterprises, NUS, Insider Sale, Form 4, Chayce David Clark, Executive Stock Sale, 10b5-1 Plan, Corporate Governance, EVP General Counsel